Tag: Lichen sclerosus

According to studies, topical tacrolimus has shown a high objective response rate for patients with anogenital lichen sclerosus, with one 2011 study reporting a 90% response rate. Yes, topical tacrolimus is used as a valuable therapeutic agent for lichen sclerosus, especially in sensitive areas where prolonged steroid use can cause issues.

According to guidelines from the British Association of Dermatologists, clobetasol propionate is a recommended first-line treatment for lichen sclerosus (LS), effectively managing symptoms and preventing disease progression. It is a potent topical corticosteroid that has been proven significantly more effective than placebo in reducing inflammation and promoting remission.